N/A
Completed N=30
Efficacy of Brooke Bond Black Tea Extract on Flow Mediated Dilation in Indian Males
Healthy
Source: ClinicalTrials.gov NCT01561300 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: 'Acute-upon-chronic Effect' of Tea vs Control — 8.03; 9.03 percentage of change in diameter — p=0.09
Summary
This study examines the effect of 1800 mg/day standardized Brooke Bond black tea extract, equivalent to 400 mg flavonoids, on Flow Mediated Dilation in healthy Indian males.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 'Acute-upon-chronic Effect' of Tea vs Control |
8.03; 9.03 | 0.09 |
| SECONDARY Acute Effect of Tea vs Control |
8.44; 8.82 | 0.70 |
| SECONDARY Chronic Effect of Tea vs Control |
9.19; 9.39 | 0.66 |
Eligibility Criteria
Inclusion Criteria
- Male volunteers aged between >\_30 \_ \_18 and \_ \_140 and >\_100 mmHg and diastolic blood pressure 70 mmHg
- Subjects who consume \_ \_ 2 cups per day)
- Apparently healthy, with no reported medical condition which might affect the assessment as judged by the study physician or/and PI
- No prescribed medical treatment that may affect study parameters as judged by the Study Physician
- Subject willing to abstain from alcohol on day before and on the day of assessment
- Willing to sign the informed consent form
Exclusion Criteria
- Smokers and/or tobacco chewers
- Those who consume regular alcohol (> 160 ml of alcohol per week)
- Reported intense sport activities > 10h/week
- Participating in any other clinical study concurrently or if participated in any study during 2 months preceding the screening visit
Data sourced from ClinicalTrials.gov (NCT01561300). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.